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Abstract
Background: As a result of reporting bias, or frauds, false or misunderstood findings may represent the majority
of published research claims. This article provides simple methods that might help to appraise the quality of the
reporting of randomized, controlled trials (RCT).
Methods: This evaluation roadmap proposed herein relies on four steps: evaluation of the distribution of the
reported variables; evaluation of the distribution of the reported p values; data simulation using parametric
bootstrap and explicit computation of the p values. Such an approach was illustrated using published data from a
retracted RCT comparing a hydroxyethyl starch versus albumin-based priming for cardiopulmonary bypass.
Results: Despite obvious nonnormal distributions, several variables are presented as if they were normally
distributed. The set of 16 p values testing for differences in baseline characteristics across randomized groups
did not follow a Uniform distribution on [0,1] (p = 0.045). The p values obtained by explicit computations were
different from the results reported by the authors for the two following variables: urine output at 5 hours
(calculated p value < 10-6, reported p ≥ 0.05); packed red blood cells (PRBC) during surgery (calculated p value = 0.08;
reported p < 0.05). Finally, parametric bootstrap found p value > 0.05 in only 5 of the 10,000 simulated datasets
concerning urine output 5 hours after surgery. Concerning PRBC transfused during surgery, parametric bootstrap
showed that only the corresponding p value had less than a 50% chance to be inferior to 0.05 (3,920/10,000,
p value < 0.05).
Conclusions: Such simple evaluation methods might offer some warning signals. However, it should be
emphasized that such methods do not allow concluding to the presence of error or fraud but should rather be
used to justify asking for an access to the raw data.
Keywords: Reporting bias; Reporting; CONSORT; Fraud
Background
In a world where medicine is supposed to be based on evi-
dence, the question of how evidence-based the published
results should be appraised and translated into clinical
practice is of crucial importance [1,2]. To facilitate the
appraisal, important efforts have been made to propose
reporting checklists, trials registries, and to extend conflict-
of-interest disclosure. The CONSORT [3] statements has
undoubtedly helped to improve the reporting of clinical
trials. The requirement of a registration number helps the
reader to verify that the methodology and the endpoints
have not changed after completing patients’ enrolment
[4,5]. Moreover, many journals now ask for professional
statisticians to review the manuscripts [6]. Despite such
efforts, the high prevalence of reporting bias as well as
several examples of high-grade research findings pub-
lished in major medical journals, but refuted by subse-
quent evidences, maintain doubts around evidence-based
medicine [7,8].
In an ideal world, major scientific journals should ask
the researchers to provide their raw data to allow an exter-
nal verification of the results [8]. However, while such
policies are lacking, it is currently difficult to verify the
accuracy of the published data. It is the editors, reviewers,
and readers’ responsibility to appraise the research reports,
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before translating the results into clinical practice. In this
context, we proposed some simple statistical screening
tools that could help to detect certain types of reporting
bias [9]. Our objective was to test whether such simple
tools applied to a manuscript known to be fraudulent
[10,11] would have helped to detect some warning signals
of poor quality. Such warning signals would have justified
asking the trialists for more detailed information concer-
ning the raw data.
Methods
We first provide a concise description of the methods pre-
viously proposed [9]: evaluation of the distribution of the
reported variables; evaluation of the distribution of the
reported p values; parametric bootstrapping and explicit
computation of the p values.
Variable distribution
In many papers, data are reported as if they were nor-
mally distributed, while usually, the authors only assume
that the data are normally distributed. First, the use of
summary statistics, such as means and standard devia-
tions, might not adequately reflect the distribution of a
nonsymmetrically distributed variable. Although rarely
followed, the CONSORT statements recommend using
mean and standard deviations (eventually associated to
the interquartile range) for symmetrically distributed
variables, and median with its interquartile range for
other variables [3]. Worse still, parametric statistical
tests, such as the Student t tests or Analysis of Variance
(ANOVA) often are inappropriately used [12]. Such tests
might be inappropriate to analyze nonnormally distri-
buted or skewed data, especially when the sample size is
not large enough. In such situations, alternatives might
either rely on using nonparametric statistical tests or
only on comparing the confidence intervals without any
statistical tests [13]. However, the fact that a variable is
nonnormally distributed does not necessarily imply that
the result of a parametric test is invalid. T test, for
instance, is quite robust to nonnormal data providing
sample size is not small and the data are not too skewed.
It also should be emphasized that several transforming
functions have been proposed to convert non-Gaussian
distributions to gaussian form, to eliminate or substan-
tially reduce non-Gaussian characteristics of positive
skewness and peakedness [13].
Hence, it is of interest to analyze the distribution of
reported variables. First, the reader should question
whether a given variable could intrinsically behave
normally or not. For example, duration variables (length
of stay in hospital or a length of mechanical ventilation,
for instance) are usually not normally distributed [12]. Be-
cause duration cannot be negative, but can trend toward
infinity, its distribution is usually asymmetric. Second, the
reported summary statistics can help the reader to refute
the assumption of normality, for example, when a strictly
positive variable has a standard deviation close to or even
larger than its mean. This means that the variable distri-
bution is wide, but also that, given the fact that negative
values are impossible, its distribution is likely to be asym-
metric. Third, critically looking at the summary statistics
can help the reader to detect some lack of variability in
the data, which can be related to data smoothing for
instance. This point can easily be checked by looking at the
variability reported in the literature for similar measures.
Baseline covariate distribution between groups
Statistical testing should be avoided when evaluating
covariate balance, because usual tests are not designed
to accept the null hypothesis. However, most published
manuscripts report such statistical tests. Analyzing the
results of such statistical tests could help to detect poor
quality data.
P values distribution
If the randomization was adequately performed, baseline
characteristics distribution should be balanced between
the two randomized groups. Under such a null hypothesis
(i.e., the two groups have similar baseline characteristics),
the p values referring to the comparisons of baseline inde-
pendent characteristics should follow an Uniform dis-
tribution over the interval [0,1] [14]. In other words, the
p values should be uniformly distributed between 0 and 1.
In case of fraud, the authors are usually tented to produce
p values all close to 1. Hence, when p values are all close
to 1, one should probably consider this result as a warning
signal. As an example, we propose to distinguish a two-
class partition of the p values (<0.5, ≥0.5), to check graph-
ically the observed distribution of the reported p values in
these two classes and to see if it is compatible with
Uniform distribution. Of course, this evaluation relies on
the fact that the authors reported all baseline characte-
ristics that they compared. If they chose not to report
some of the baseline covariates, such an adequacy test to
Uniform distribution could not be adequately performed
on the subset of reported p values due to missing—and
potentially informative—p values.
Explicit p value computations
Based on the reported summary statistics (means and
standard deviations for instance), one also could com-
pute the p value of a Student t test (formula provided in
Additional file 1). The p values for Fisher and Chi-square
tests also can be computed retrospectively from the data
reported in a contingency table. Moreover, it should be
emphasized here that p values are probabilities that are
use to reject or not the null hypothesis according to some
prespecified rejection rules. Multiplying statistical tests
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intrinsically inflates the type I error, i.e., the probability to
reject the null while in fact it is the truth. To address this
risk, one should adapt the prespecified rejection rules—
that is adjust the p value threshold for statistical signifi-
cance [15].
Parametric bootstrap
The parametric bootstrap [16] is a simulation procedure
that consists in randomly generating many independent
datasets on the basis of the reported characteristics of the
population and some knowledge about the distribution
law. Simulations allow one to recreate a large number of
virtual datasets retrospectively. Simulating a dataset re-
quires: 1) a location parameter (mean or median for
example); 2) a dispersion parameter (standard deviation or
95% confidence intervals for example); and 3) some know-
ledge about the distribution law. The parametric bootstrap
consists in randomly generating N independent datasets of
size n on the basis of the reported sample size, mean and
variance (Additional file 1). Let’s consider that a variable,
such as age, is reported with a mean of 60 years with a SD
of 40 in a sample of size 1,000. If one assumes that age is
usually normally distributed in the population, one can use
the reported mean and SD to draw N independent sample
from a Normal distribution with mean 60 and SD 40. The
simulated datasets may first be used to look at the distribu-
tion of the data with two specific questions: 1) Is this distri-
bution possible? (e.g., it is obviously impossible to observe
negative values for a variable such as serum creatinine);
2) Is the distribution compatible with the variable itself? (e.g.,
variable for which the measurement method has a large
intrinsic variability should have a variance in agreement).
Second, it is possible to rerun the statistical analyses in each
simulated dataset using the same tests as those used by
the authors and building the distribution of the p values.
It should be emphasized that such an approach does
not aim to provide new inference but only to detect
some potential inconsistencies. Moreover, variable simu-
lation from reported means and standard deviations rely
on an assumption concerning the underlying distribu-
tion. Because some variables are obviously not normally
distributed, it could be of interest to compare simula-
tions under normal distribution to simulations obtained
under alternate distributions. Finally, simulating 10,000
datasets is not the same as “redoing 10,000 times the
same clinical trial, with the same sample size.” In such
simulations, we assume observed means and standard
deviations are the true population parameters, while they
are in fact the observed parameters of a random sample
drawn from the underlying population.
Illustrative example
To illustrate these methods, we selected the data from a
randomized study published in 2009 [10] that was based
on two groups of 25 patients (Additional file 2). We
chose this paper because it is known to be fraudulent
and it was retracted by the Editor-in-Chief of the journal
in 2010 [11]. To perform our retrospective simulations,
we selected in this paper the continuous variables, the
mean and the standard deviation of which were tabu-
lated. Assuming that the reporting was appropriate, we
considered that, when such variables were expressed as
mean (SD), they should be normally distributed. We
then used these reported means, standard deviations and
the normal distribution assumption to build N = 10,000
datasets of size n = 50 (25 subjects in each group). Based
on these simulated datasets, we reran the statistical
analysis using Student t tests, and plotted the distribu-
tion of the observed p values across the 10,000 datasets.
In addition, to address the skewed distribution of some
variables, we also used the reported mean and standard
deviations to simulate lognormal observations, and reran
the analyses using nonparametric rank-sum tests.
We identified 19 tabulated continuous variables sup-
posed to be normally distributed and for which a mean
and a standard deviation were reported.
Results
Variables distribution
First, variables, such as duration of anesthesia, cardiopul-
monary bypass (CPB), cross-clamp, and intubation, were
presented using mean and standard deviation, whereas
they are usually not normally distributed (Additional file
2: Table S1a). Second, the standard deviations for the
volume of packed red blood cell (PBRC) and fresh frozen
plasma (FFP) are far too large compared with their mean
value (Additional file 2: Table S1b). As a volume cannot
be negative, it is likely that these variables are not sym-
metrically distributed, so that the assumption underlying
the use of parametric statistical tests might not hold
(Figure 1A). Third, the variability of cytokines’ measure-
ments reported in this paper is far lower than the one pre-
viously reported in the literature for similar study designs.
This last point is the one that was detected by several
readers, which led to the retraction.
P values distribution
Under the null hypothesis of no intergroup difference
after adequate randomization, the set of 16 p values
presented in the Additional file 2: (Table S1a) should
follow a Uniform distribution on (0,1). This means that,
among 16 random values, on average, 8 are expected to
be <0.5. In the present case, however, more p values
were >0.5 (Figure 1B).
Explicit computations
Based on the reported means and standard deviations in
each randomized groups reported in the Table b, we
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Example of Normal Distribution Distribution of a Strictly Positive Variable
C
B
A
Example of Uniform (0,1) Distribution Observed p-values distribution
Simulated p-values for Urine Output at 5h Simulated p-values for PRBC during surgery
Figure 1 Illustration of the checking procedure. A Variable distribution. The variable FFP during surgery is described with a mean of 60 and a
SD of 210. As shown in the left panel, if this variable was normally distributed, it should exhibit some negative values. Because negative values
are impossible for such a variable, its distribution is necessarily asymmetric (right panel: example of a strictly positive variable characterized by a
large SD). B P value distribution under the null hypothesis. Left panel represents the theoretical distribution of the p values under the null
hypothesis, that is a uniform (0,1) distribution: p values are equally distributed on both sides of the middle line. As shown in the right panel, the
observed p values are likely not to be distributed uniformly. C Distribution of the simulated p values corresponding to the comparison of two
variables in the two groups across the 10,000 simulated datasets. The left panel shows a very high probability for the comparison of the urine
output at 5 hours to be statistically significant, whereas it was reported as nonsignificant by the authors. The left panel shows the distribution of
the simulated p values concerning the comparison of the PRBC during surgery: the black vertical line represents the 0.05 threshold of statistical
significance, and the dashed line represents the p value that has been explicitly computed, given the observed mean and SD in the two groups.
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recalculated the p values. Using this method, the results
also were different from those reported by the authors
for the two following variables:
– Urine output at 5 hours: p < 10-6 (comparison
reported as nonsignificant by the authors)
– PRBC during surgery: p = 0.08 (comparison
reported as statistically significant in the paper)
Parametric bootstrap
We limited the simulations to those variables where (1)
there seemed to be some clinical differences between the
groups, but the authors reported no statistical difference,
(2) the authors reported a statistically significant diffe-
rence but such a difference did not seem to be of clinical
relevance, or (3) the normal distribution assumption
seemed to be violated. The results of the simulation are
given in Table 1. Figure 1C exemplified two situations
where the probability of finding the results the authors ac-
tually reported was low: the authors reported a nonsta-
tistically significant difference in terms of urine output
5 hours after surgery, but the simulation found p > 0.05 in
only 5 of the 10,000 simulated datasets; the volume of
PRBC transfused during surgery was reported to be sig-
nificantly higher in the Albumin group, but simulation
showed that the probability to observe p < 0.05 was
smaller than 0.4 (3,920/10,000, p < 0.05). Finally, to ad-
dress the nonsymmetry of some variables, we also used
the reported mean and standard deviations to simulate
lognormal observations, and reran the analyses using non-
parametric rank-sum tests. As reported in Table 1, results
were very similar.
Discussion
We proposed a critical appraisal of the results of ran-
domized control trials based on a multisteps procedure
(Figure 1): evaluation of the distribution of the reported
variables; evaluation of the distribution of the p values
reported for the comparison of the baseline characte-
ristics of the two groups; explicit computation of the
p values and parametric bootstrap. The roadmap does
not aim at diagnosing fraud or bias but rather at
detecting some potential warnings that could be used by
reviewers or editors as justifications to address queries
on the raw data. If present, such warnings do not neces-
sarily imply fraud but might only be related to some
misuse of the statistical methods. Whether or not such
misuses rely on fraud can be adjudicated by analyzing
the raw data with variety of methods. Thereafter, the
reluctance to share data might be considered as a further
clue of poor quality study. Indeed, Wicherts et al. [17]
recently reported that authors’ reluctance to share data
is associated with more error in reporting of statistical
results and with weaker evidence. Providing the avail-
ability of raw data, some authors have proposed to check
more precisely the data distribution. For instance,
looking at the kurtosis of the distribution, which is a
measure of the shape of the distribution, might be of
interest. Even if even an astute cheater would preserve
the mean and the variance, he may be tripped up by
examination of the kurtosis [6]. Another approach is to
look at the reported numbers and especially at their
digits. Indeed, the Benford’s law [18] stipulates that,
under certain conditions, the distribution of the first
digit of a variable follows a special logarithmic distribu-
tion [15]. This law might be used to check the random-
ness of the numbers reported in a paper [6]. Eventually,
Masicampo et al. [19] focused on the prevalence of p values
just greater than 0.05. They examined the distribution of
p values reported in a large subset of papers from three
highly regarded psychology journals. P values were much
more common immediately less than 0.05 than would be
expected based on the number of p values occurring in
other ranges. The authors discussed potential sources of
this pattern, including publication bias and researcher
degrees of freedom. Those approaches could in turn be
associated with those we suggested.
If absent, such warning signals do not exclude the
presence of publication bias. Moreover, careful analysis
might still fail to address other sources of bias, such as
selective reporting (e.g., reporting of observations that have
reached significance only) and publication bias (e.g., selec-
tive, faster, and more prominent publication of research
Table 1 Distribution of the p values corresponding to the
comparison of the two groups across the 10,000
simulated datasets
p < 0.05
Variable Normal
distribution
Lognormal
distributions
Colloids 5 hr after surgery 9,113/10,000 8,969/10,000
Urine output 5 hr after
surgery
9,995/10,000 9,985/10,000
PRBC volume
During surgery* 3,920/10,000 5,371/10,000
5 hr after surgery* 5,114/10,000 6,601/10,000
Until first POD* 5,533/10,000 7,133/10,000
Until second POD* 4,633/10,000 5,742/10,000
FFP
during surgery 879/10,000 2,133/10,000
5 hr after surgery* 4,377/10,000 8,412/10,000
Until first POD* 5,880/10,000 9,446/10,000
Until second POD* 5,874/10,000 9,424/10,000
Number of p < 0.05 observed across the 10,000 simulated datasets.
Simulations were performed using either normal or lognormal distributions.
Comparisons were performed using non parametric Wilcoxon tests.
*Statistically significant comparison according to the authors.
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findings that produced unusual, very strong, highly signifi-
cant results) [17].
To illustrate our four-step procedure, we have applied
it to analyze the data reported by Boldt et al. in an
article that has been recently retracted for fraud [10,11].
It should be pointed out that the Editor-in-Chief decided
to retract the article after several letters were sent to the
journal pointing out the surprisingly small variability in
cytokines measurements reported in the paper. Using
this article as an example helped us to illustrate that, even
though each step of our approach might be well known by
statistically trained reviewers or readers, strictly applying
this four-step procedure could have provided some impor-
tant warning signals when apprising Boldt’s manuscript.
This series of analyses have some limitations. First, these
analyses alone may not enable to discriminate between
low- and high-quality data, because there is variety of
sources of bias that may not be explored. However, in the
context of medical diagnosis, we usually oppose screening
vs. diagnostic tools. We ask a diagnostic tool to be very
specific, while we essentially ask a screening tool to be
sensitive. The objective is to offer to the patients a strategy
based on a first “screening” line of exams (highly sensitive),
which in case of positive results, would need to be
confirmed by a second line of diagnostic exams (highly
specific) in order to detect the potential false-positives.
We think that our series of analysis should be considered
as a second line of exams. It is definitely not sensitive
enough to detect fraud or poor quality data in the whole
“population” of manuscripts. The first “screening” line
should be the Reviewer (or when the manuscript is already
published, the reader’s own criticism sense) and even bet-
ter, the statistical Reviewer. When dealing with potentially
fraudulent data, it seems crucial to offer a multiple line
screening. As stated by Haldane (“second order faking”),
when data are fabricated to pass certain statistical tests,
they are likely to fail on others [20]. Second, the series of
analyses were illustrated by applying it to a single set of
data [10]. A complete validation process would be needed
in the near future by applying it, in a blinded manner, to a
series of manuscripts. Third, the step based on parametric
bootstrap may somehow be compared to retrospective
power analysis, which is highly controversial [21].
Conclusions
There is increasing concern that in modern research,
false findings may be the majority of published research
claims [4]. This can be view as the result of different
types of fraud, or, more commonly, of inappropriate use
of standard statistical tools. Simple evaluations of the
reported data as those reported in the present note
might offer some warning signals. Because the described
methods are quite general, the presence of such warning
signals should prompt asking for raw data, in order to
appraise critically the quality and the validity of the data,
using additional more specific tools, shaped to explore
both distribution and reporting of a given variable [6].
For the future, we should concentrate our efforts to
organize systematic publication of the raw data, in order
to allow independent validation of the results [22-24].
Until systematic raw data access becomes the rule, the
proposed tools could serve as a “lecture schedule” for
both readers and reviewers.
Key messages
– Poor-quality evidence and fraud are upcoming
concerns in medical research
– Reporting guidelines should be strictly followed and
imposed by medical journals
– Guidelines should be provided to reviewers to offer
homogeneous evaluation of some reporting key
points
– Similar simple screening tools should be available
for the readers.
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